Group One Trading’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6,212
Closed -$4.2M 8111
2025
Q4
$4.2M Buy
6,212
+4,670
+303% +$3.18M 0.01% 1664
2025
Q3
$985K Buy
1,542
+943
+157% +$572K ﹤0.01% 3045
2025
Q2
$321K Buy
599
+511
+581% +$244K ﹤0.01% 3858
2025
Q1
$37K Buy
88
+83
+1,660% +$36K ﹤0.01% 5389
2024
Q4
$2.07K Buy
+5
New +$2.19K ﹤0.01% 6722
2023
Q4
Sell
-83
Closed -$39K 7739
2023
Q3
$36.3K Buy
+83
New +$41.4K ﹤0.01% 5392
2022
Q2
Sell
-3,784
Closed -$1.54M 8113
2022
Q1
$2.07M Sell
3,784
-5,446
-59% -$2.86M ﹤0.01% 2365
2021
Q4
$6.08M Buy
+9,230
New +$5.79M ﹤0.01% 1531
2017
Q3
Sell
-400
Closed -$63.2K 4967
2017
Q2
$65K Buy
+400
New +$65K ﹤0.01% 3362

Other funds holding IDXX

Group One Trading's IDXX Position: Q1 2026 in Review

Group One Trading sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 6,212 shares — an estimated $4.2M sold.

Group One Trading first reported a position in IDXX in Q2 2017 and held it in 9 quarters. The position peaked at $6.08M in Q4 2021. 1,318 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Group One Trading reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 6,212 Idexx Laboratories shares in Q1 2026, an estimated $4.2M.
  • Group One Trading first reported a position in Idexx Laboratories in Q2 2017 and held it in 9 quarters.
  • Group One Trading's Idexx Laboratories position peaked at $6.08M in Q4 2021.
  • 1,318 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.